Evidence map›Paper›PMID 40369269›Full record

ArticleNPJ digital medicine2025

Development and validation of a deep learning model for diagnosing neuropathic corneal pain via in vivo confocal microscopy.

Neslihan Dilruba Koseoglu, Eric Chen, Rudraksh Tuwani, Benjamin Kompa, Stephanie M Cox, M Cuneyt Ozmen, Mina Massaro-Giordano, Andrew L Beam, Pedram Hamrah

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Electrotherapy in the management of neuropathic corneal pain: narrative review.Experimental biology and medicine (Maywood, N.J.) · 2026
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Neslihan Dilruba Koseoglu *Center for Translational Ocular Immunology and Cornea Service, New England Eye Center, Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA.ORCID http://orcid.org/0000-0001-9268-1461
Eric Chen *Harvard-MIT Program in Health Sciences and Technology, Boston, MA, USA.
Rudraksh TuwaniDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Benjamin KompaDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Stephanie M CoxCenter for Translational Ocular Immunology and Cornea Service, New England Eye Center, Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA.
M Cuneyt OzmenCenter for Translational Ocular Immunology and Cornea Service, New England Eye Center, Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA.
Mina Massaro-GiordanoScheie Eye Institute, Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USA.
Andrew L Beam *Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Andrew_Beam@hms.harvard.edu.ORCID http://orcid.org/0000-0002-6657-2787
Pedram Hamrah *Center for Translational Ocular Immunology and Cornea Service, New England Eye Center, Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA. pedram.hamrah@tufts.edu.

Funding

Discovery of the Biomarker Signature for Neuropathic Corneal PainR61NS113341 · NINDS · TUFTS MEDICAL CENTER · PI HAMRAH, PEDRAM · 2019 to 2019
$2.1M
NINDS NIH HHS R61 NS113341U.S. Department of Health & Human Services | National Institutes of Health (NIH) R61NS113341
6 · The paper itself

Abstract

Neuropathic corneal pain (NCP) is an underdiagnosed ocular disorder caused by aberrant nociception and hypersensitivity of corneal nerves, often resulting in chronic pain and discomfort even in the absence of noxious stimuli. Recently, microneuromas (aberrant growth and swelling of the corneal nerve endings) detected using in vivo confocal microscopy (IVCM) have emerged as a promising biomarker for NCP. However, this process is time-intensive and error-prone, limiting its clinical use and availability. In this work, we present a new NCP screening system based on a deep learning model trained to detect microneuromas using a multisite dataset with a combined total of 103,168 IVCM images. Our model showed excellent discriminative ability detecting microneuromas (AuROC: 0.97) and the ability to generalize to data from a new institution (AuROC: 0.90). Additionally, our pipeline provides an uncertainty quantification mechanism that allows it to communicate when its predictions are reliable, further increasing its clinical relevance.

Identifiers

PMID40369269
PMCPMC12078480

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.